Specific inhibition of estrogen receptor alpha function by antisense oligodeoxyribonucleotides

Antisense and Nucleic Acid Drug Development

Volumn 11, Issue 4, 2001, Pages 219-231

  Taylor, A H ^a   Pringle, J H ^a   Bell, S C ^a   Al Azzawi, F ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; ANTISENSE OLIGODEOXYNUCLEOTIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA;

ARTICLE; BINDING AFFINITY; BREAST CARCINOMA; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; ESTROGEN METABOLISM; GENE TRANSFER; HUMAN; HUMAN CELL; INHIBITION KINETICS; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REDUCTION; WESTERN BLOTTING;

EID: 0034856928     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729001317022223     Document Type: Article

References (55)

1. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies
2. Proteosome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation
3. Regular bleeding on hormone replacement therapy: A myth?
4. Stimulation of estrogen receptor-mediated transcription and altered phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
5. Characterization and co-culture of novel nontransformed cell lines derived from rat endometrial epithelium and stroma
6. Uterine gene transfection with a HOXA10 antisense oligonucleotide prevents implantation
7. 5-En-androstene-3β,17β-diol inhibits the growth of the MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol
8. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
9. Evidence for soluble and nuclear site I binding of estrogens in human aorta
10. In vivo gene transfer to the uterine endometrium
11. Noninfectious gene transfer and expression systems for cancer gene therapy
12. Antisense therapy for lymphomas
13. Estrogen receptor null mice: What have we learned and where will they lead us?
14. Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: Effects of ligand binding on receptor-DNA complexes
15. Membrane effects of thyrotropin-releasing hormone and estrogen shown by intracellular recording from pituitary cells
16. Protein synthesis is not implicated in the ligand-dependent activation of the estrogen receptor MCF-7 cells
17. Implications of proteosome in estrogen receptor degradation
18. The steroid and thyroid hormone receptor superfamily
19. Identification of a new class of steroid hormone receptors
20. Sequence and expression of human estrogen receptor complementary DNA
21. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells - Relationship between processing and estrogenicity
22. Estrogen and progesterone receptor mRNA are expressed in distinct pattern in male primate reproductive organs
23. Bovine endometrial epithelial cells as a model system to study oxytocin receptor regulation
24. Estradiol up-regulates estrogen receptor-alpha messenger ribonucleic acid in sheep endometrium by increasing its stability
25. Estradiol enhances gene delivery to human breast tumor cells
26. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
27. Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase
28. Calbindin-D9k gene expression in the uterus: Study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element
29. The specific binding of estradiol and estrone and the subsequent distribution of estrogen-receptor complexes within MCF-7 human breast cancer cells
30. Estrogen responses to bovine fetal uterine cells involve pathways directed by both estrogen response element and activator protein-1
31. Tamoxifen and hydoxytamoxifen isomers versus estradiol effects on normal human breast cells in culture
32. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
33. Selective estrogen receptor modulators: A look ahead
34. Development of immortalized endometrial epithelial and stromal cell lines from the mink (Mustela vison) uterus and their effects on the survival in vitro of mink blastocysts in obligate diapause
35. Proteosome-dependent degradation of the human estrogen receptor
36. Membrane receptors for steroid hormones: A case for specific surface binding sites for vitamin D metabolites and estrogens
37. The steroid receptor superfamily: More excitement predicted for the future
38. A one minute pulse of estradiol to MCF-7 breast cancer cells changes estrogen receptor binding properties and commits cells to induce estrogenic responses
39. Searching for the ideal SERM
40. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells
41. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors
42. The nuclear hormone receptor gene superfamily
43. Oligonucleotide squelching reveals the mechanism of estrogen receptor autologous downregutation
44. Achieving long-term continuance of menopausal ERT/HRT: Consensus opinion of The North American Menopause Society
45. Antisense oligodeoxyribonucleotides - Highly specific tools for basic research and pharmacotherapy
46. Pharmacokinetics and tolerability of intravenous trecovirsen (GEMrho91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects
47. The mouse estrogen receptor-related orphan receptor alpha1: Molecular cloning and estrogen responsiveness
48. Intracellular receptor concentration limits glucocorticoid dependent enhancer activity
49. Antisense strategy in hematological malignancies
50. The limits of the cellular capacity to mediate an estrogen response
51. Antisense inhibition of IGF receptor expression in Ha-CaT keratinocytes: A model for antisense strategies in keratinocytes
52. Structural organization and expression of the mouse estrogen receptor
53. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
54. Attenuation of calcitonin gene expression in pregnant rat uterus leads to a block in embryonic implantation
55. Neuroactive steroids: Their mechanism of action and their function in the stress response